Biontech closes almost all German production sites after pandemic boom
Biontech, the Mainz-based biotechnology company that earned billions during the pandemic with its Covid-19 vaccine Comirnaty, is shutting down nearly all of its German production sites. The announcement, made last week, follows the March exit of founding couple Uğur Sahin and Özlem Türeci from operational management and the company's first billion-euro loss. After a meteoric rise during the Corona era, the former flagship company is now collapsing like a soufflé, leaving angry employees behind.
Key facts
- Biontech earned billions during the pandemic with the Covid-19 vaccine Comirnaty, partly using tax money.
- The company announced it is ending vaccine production in Germany and closing several sites.
- In March, founding couple Uğur Sahin and Özlem Türeci withdrew from operational management.
- Biontech reported its first billion-euro loss.
- The company's rise was meteoric during the Corona period.
- The closures leave employees angry.
- The announcement was made last week.
- Biontech is based in Mainz.
Entities
Institutions
- Biontech
Locations
- Mainz
- Germany